Table of Contents
Key Takeaways
|
The rise of generative AI is changing how pharma researchers approach respondent recruitment, particularly when studies involve hard-to-reach healthcare professionals (HCPs). Synthetic respondents offer potential advantages in terms of speed, scalability, and access to simulated respondent profiles. At the same time, primary research in healthcare relies on direct responses from qualified healthcare professionals with actual clinical and practice experience.
The key question is not simply whether synthetic respondents can produce responses that resemble those of HCPs, but whether they adequately represent the population and research context being studied. Understanding this distinction is particularly important in pharma research, where specialty, clinical experience, and practice setting can influence responses. This article explores where synthetic respondents fit within pharma market research, their limitations, and whether they can replace real HCPs in pharma market research.
What are Synthetic Respondents in Pharma Market Research?
A synthetic respondent is an AI-generated persona designed to simulate responses from a defined research participant. In pharma primary market research, a synthetic HCP respondent represents a specified healthcare professional profile and generates simulated research responses based on the characteristics, information, or data used to develop the model.
More sophisticated approaches may use historical survey data or respondent-level data to model synthetic populations. Synthetic respondents differ from other applications of AI and synthetic data:
| Term | What It Means |
| Synthetic HCP respondent | An AI-generated respondent designed to represent a defined HCP profile and generate simulated research responses. |
| Generic AI role-play | An AI system prompted to respond as a physician or other HCP without necessarily representing a defined research population or respondent model. |
| Synthetic healthcare or clinical data | Artificially generated data designed to replicate characteristics of healthcare or clinical datasets, rather than responses from simulated research participants. |
| Real HCP using AI | A human healthcare professional who completes a survey or research activity with assistance from an AI tool. The respondent remains a real HCP. |
Read Also: 8 Challenges in Conducting Market Research Among Patients With Multiple Chronic Conditions
Why are Pharma Researchers Exploring Synthetic HCPs?
Recruiting specialized HCPs for pharma research requires participants who meet specific specialty, practice, experience, and other eligibility criteria. Niche specialties and tightly defined respondent profiles can make recruitment more difficult, particularly when a study requires a specific combination of characteristics.
Research teams are exploring synthetic HCPs for their potential to:
- Reduce reliance on full-scale human recruitment
- Test research materials more quickly
- Explore hypotheses before human fieldwork
- Simulate multiple defined HCP profiles at scale
- Explore different respondent profiles without full fieldwork
Where Do Synthetic Respondents Add Value?
Synthetic respondents may add value during early-stage research, particularly when researchers test or refine research approaches before human fieldwork.
Questionnaire and Concept Pretesting
Synthetic respondents may help researchers:
- Test questionnaire wording and structure
- Identify confusing or difficult questions
- Examine potential interpretations of research questions
- Compare early concepts or message variations
- Identify issues before human fieldwork
Early-Stage Research and Hypothesis Exploration
Synthetic samples may also support pilot-stage research by helping researchers:
- Explore potential research hypotheses
- Examine early concepts and messages
- Identify questions for subsequent human research
- Explore different perspectives within defined profiles
Pilot and Research Design Work
Synthetic samples may also support pilot-stage research by helping teams:
- Test proposed research approaches
- Examine possible respondent journeys
- Pretest interview guides and survey instruments
- Refine research materials before fieldwork
These applications position synthetic respondents as a preparatory research tool, rather than a substitute for human respondents.
Read Also: Subscription-Based Healthcare Models: Are Patients Ready for the Shift?
What are the Challenges of Using Synthetic HCPs?
Using synthetic HCPs introduces methodological challenges around the relevance and reliability of generated responses.
Representation and Population Validity
A synthetic respondent may produce a plausible physician response without representing the target HCP population. Defining a physician persona is not the same as reproducing the characteristics and response patterns of a specific research population.
Relevant population characteristics include:
- Medical specialty
- Geography
- Practice setting
- Clinical experience
- Patient population
Response Variation and Human Differences
Real HCPs do not respond identically to the same research question. Individual responses reflect differences in experience, preferences, knowledge, and clinical practice.
Research on LLM-generated survey responses has found lower response variation in some synthetic samples than in human survey data. A synthetic sample that approximates an overall average may therefore fail to reproduce the distribution of individual responses.
Prompt Sensitivity and Reproducibility
Synthetic responses may change when researchers modify prompt wording, even when the underlying research question remains similar. Research has also identified changes in response patterns across model conditions and over time.
This creates challenges when researchers need consistent results that remain reproducible under defined research conditions.
Read Also: Subscription-Based Healthcare Models: Are Patients Ready for the Shift?
Specialty and Practice Context
A generic physician persona does not automatically represent a specific HCP population. Responses may depend on:
- Clinical specialty and experience
- Practice environment
- Patient population
- Healthcare system
- Treatment experience
These distinctions matter in pharma research when the target population consists of HCPs with specific clinical roles, treatment experience, or practice settings.
Validation, Transparency, and Governance
Synthetic respondents require validation against relevant human data for the intended research population and purpose. Validation in one population does not establish suitability for another.
Researchers also need transparency around how synthetic respondents are generated, what data informs them, and how their performance is assessed. According to the ICC/ESOMAR International Code, researchers should address transparency, accountability, data sources, limitations, and appropriate human oversight when AI and synthetic data or personas are used in research.
The FDA and EMA also emphasize context of use, data governance, documentation, performance assessment, and human oversight in their principles for AI use in drug development. These principles provide relevant methodological considerations, although they do not specifically establish requirements for synthetic HCP respondents in pharma market research.
Read Also: Top Healthcare Market Research Trends Shaping the Industry in 2026 and Beyond
Synthetic Respondents vs. Real HCPs
A direct comparison highlights how synthetic respondents and real HCPs differ in their data sources, respondent characteristics, and research requirements.
| Factor | Synthetic Respondents | Real HCPs |
| Response source | AI-generated responses | Direct responses from human participants |
| Professional experience | Simulated or model-based | Based on actual professional experience |
| Population representation | Depends on model design and validation | Based on recruited respondents meeting defined criteria |
| Respondent selection | Defined through model parameters or persona characteristics | Defined through recruitment and screening criteria |
| Specialty targeting | Depends on model capabilities and available data | Defined through HCP recruitment and screening |
| Practice context | Represented through model inputs or persona characteristics | Reported by the participating HCP |
| Response variation | Depends on model behavior and generation conditions | Reflects variation among individual participants |
| Prompt or question effects | Responses may vary with prompt wording | Responses reflect the questions presented to participants |
| Qualitative probing | Interaction with the AI model | Direct probing and follow-up with HCPs |
| Clinical experience | Simulated from model information | Drawn from the HCP’s actual experience |
| Validation | Requires validation against relevant human data | Requires respondent screening and data-quality checks |
| Reproducibility | May be affected by prompts, model versions, and model changes | Depends on sampling, fieldwork, questionnaire, and data-quality procedures |
Can Synthetic Respondents Replace Real HCPs?
Synthetic respondents are not a blanket replacement for real HCPs in pharma market research. Their suitability depends on the research objective, target population, level of HCP specialization, and available validation evidence. It also depends on whether the study requires direct input from professionals with relevant clinical or practice experience.
Current evidence supports synthetic respondents more clearly for certain exploratory and preparatory applications that complement human research. Whether they can replace human fieldwork depends on the specific research context and the level of evidence supporting the synthetic approach. The available research does not support either a universal replacement claim or a universal prohibition.
Read Also: When to Use Quantitative Research Over Qualitative in Healthcare Studies
Where Does Real HCP Primary Research Remain Important?
Direct participation remains particularly relevant when primary research in healthcare requires current, experience-based responses from defined HCP populations.
- Actual clinical and professional experience
- Specialized HCP populations with defined criteria
- Real prescribing and treatment experiences
- Complex clinical and treatment decisions
- Unmet needs in real-world practice
- Qualitative research requiring probing and follow-up
- Current experience with new or evolving therapies
How Unimrkt Healthcare Supports Primary HCP Research
Direct HCP participation requires access to appropriately profiled respondents and research methods suited to the study design. Unimrkt Healthcare provides primary market research services with access to 500,000+ healthcare professionals across 20 geographies, including physicians and specialists.
Our HCP recruitment process uses detailed respondent profiles covering factors such as specialty, subspecialty, practice type, years of experience, place of practice, patient volume, and therapeutic area. We also apply respondent authentication and data-quality checks throughout the research process to help verify participant eligibility and response quality. As one of the specialized healthcare primary research firms, we support online surveys, CATI, qualitative research, and quantitative research.
Read Also: Why Digital Healthcare Payers are Investing in Fraud and Payment Integrity Research
Connect With Unimrkt Healthcare
Unimrkt Healthcare is a specialized healthcare-focused market research company supporting organizations across pharmaceuticals, medical devices, digital health, healthcare providers, healthcare payers, and animal healthcare. Through structured primary research, we engage patients, physicians, payers, administrators, and other healthcare stakeholders to collect reliable data across diverse healthcare markets and research objectives.
Backed by global research capabilities spanning 90+ countries and 22+ languages, we support qualitative and quantitative research, healthcare stakeholder engagement, surveys, in-depth interviews, and end-to-end research execution across diverse healthcare markets. Our processes align with internationally recognized standards, including ISO 20252 and ISO 27001, supporting quality, data security, and compliance throughout every study. To learn more about our healthcare research capabilities, contact us at +91-124-424-5210 or +91-9870-377-557, email sales@unimrkthealth.com, or fill out the contact form on our website, and our team will connect with you promptly.
Frequently Asked Questions
What is the Difference Between Synthetic HCP Data and Real HCP Research?
Synthetic HCP data consists of AI-generated responses from modeled HCP profiles, while real HCP research collects responses directly from qualified healthcare professionals. Real HCP research draws on participants’ actual professional experience, practice context, and reported experiences.
Is Synthetic HCP Data Accurate Enough for Pharma Market Research?
Suitability depends on the research objective, target population, model design, and validation against relevant human data. Synthetic responses should be assessed for the specific research context rather than treated as equivalent to human responses by default.
When Should Pharma Companies Use Real HCP Primary Research?
Real HCP research is particularly relevant when a study requires direct professional experience, specialized HCP populations, prescribing or treatment experiences, or qualitative probing. The appropriate primary research methodologies depend on the research objective, target respondents, and information required.
How Does Unimrkt Healthcare Recruit HCPs for Primary Research?
Unimrkt Healthcare recruits and profiles HCPs based on criteria such as specialty, subspecialty, practice type, years of experience, place of practice, patient volume, and therapeutic area. Respondent authentication and data-quality checks support participant eligibility and response quality.
What Types of Research Questions Require Real HCP Responses?
Research questions involving actual clinical experience, prescribing behavior, treatment decisions, unmet needs, or current practice experiences require direct input from relevant HCPs. This makes primary research in healthcare particularly relevant when the research objective depends on current, experience-based responses.
Can Synthetic Respondents Be Used Before Conducting Human HCP Research?
Yes. Synthetic respondents may support early-stage questionnaire or concept testing by helping researchers identify unclear wording, difficult questions, or potential issues before human fieldwork. Their use at this stage does not establish that they represent the target HCP population.
